78% Remission Rate: Digital CBT for Generalized Anxiety Outperforms Psychoeducation in 351-Patient RCT
- RCT with 351 adults with GAD (mean age 40.6, 73.8% women). Smartphone-delivered digital CBT (DCBT) vs psychoeducation control
- DCBT remission rate: 77.7% at 24 weeks vs 52% for psychoeducation. Large effect sizes: Cohen d = 1.09 at week 10, d = 0.96 at week 24
- GAD-7 scores: DCBT 7.2 vs psychoeducation 10.7 at 24 weeks (P < .001) — moving from severe to mild range
- Techniques: cognitive restructuring, applied relaxation, stimulus control, avoidance reduction, mindfulness, problem solving, imaginal exposure — full CBT protocol, not a watered-down version
A 78% remission rate for GAD from a smartphone app. Not a wellness tool, not a chatbot — a structured CBT protocol delivered digitally with the full therapeutic toolkit. This JAMA Network Open RCT does not prove digital therapy replaces therapists. It proves that well-designed digital CBT is a legitimate treatment modality, not a stopgap.
The effect size
Cohen's d of 1.09 at 10 weeks is a large effect by any standard. For context: face-to-face CBT for GAD typically produces effect sizes of 0.8–1.2. Digital delivery is landing in the same range — not as a pale substitute, but as a format that accesses patients who would never sit in a therapist's office.
The 24-week data matters most. The effect size was 0.96 — still large, with minimal decay. This is not a transient benefit that fades when the app notifications stop. The skills transferred.
What changed in these patients
The protocol was not simplified for digital delivery. Cognitive restructuring, imaginal exposure, stimulus control, applied relaxation, avoidance reduction — this is the full CBT anxiety toolkit. The app did not replace the therapist's clinical reasoning; it replaced the therapist's scheduling constraints.
The control group received psychoeducation — not nothing. A 52% remission rate from psychoeducation alone is clinically meaningful, which makes the 26-percentage-point advantage of digital CBT even more impressive.
For your practice
This is a referral option for patients on your waitlist, patients who refuse face-to-face, and patients in areas without GAD-trained therapists. It is also a stepped-care tool: start with digital CBT, escalate to therapist-delivered treatment if the patient does not remit.
Smartphone-delivered CBT achieved 78% remission in GAD at 24 weeks with effect sizes matching face-to-face therapy — redefining digital treatment from stopgap to legitimate modality.
Active control (psychoeducation), not waitlist — true effect size vs no treatment is unknown. Participants were motivated enough to use an app consistently. Severe comorbidity was excluded. Single study — replication needed.